Rile Li

3.7k total citations
37 papers, 3.0k citations indexed

About

Rile Li is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Rile Li has authored 37 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 17 papers in Pulmonary and Respiratory Medicine and 8 papers in Oncology. Recurrent topics in Rile Li's work include Prostate Cancer Treatment and Research (17 papers), Prostate Cancer Diagnosis and Treatment (6 papers) and PI3K/AKT/mTOR signaling in cancer (5 papers). Rile Li is often cited by papers focused on Prostate Cancer Treatment and Research (17 papers), Prostate Cancer Diagnosis and Treatment (6 papers) and PI3K/AKT/mTOR signaling in cancer (5 papers). Rile Li collaborates with scholars based in United States, Spain and Türkiye. Rile Li's co-authors include Thomas M. Wheeler, Gustavo Ayala, Anna Frolov, Michael Ittmann, Gustavo E. Ayala, Hong Dai, David R. Rowley, Timothy C. Thompson, Peter T. Scardino and Michael Powell and has published in prestigious journals such as Cancer Cell, Cancer Research and Clinical Cancer Research.

In The Last Decade

Rile Li

37 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rile Li United States 29 1.5k 1.1k 854 569 324 37 3.0k
Anna Frolov United States 32 1.8k 1.2× 1.3k 1.2× 1.0k 1.2× 753 1.3× 202 0.6× 55 3.6k
Laura Rosanò Italy 35 2.1k 1.4× 483 0.4× 915 1.1× 671 1.2× 97 0.3× 63 3.7k
Erik J. Uhlmann United States 30 1.7k 1.1× 589 0.5× 734 0.9× 447 0.8× 110 0.3× 73 3.4k
Valeriana Di Castro Italy 33 2.0k 1.3× 433 0.4× 833 1.0× 641 1.1× 89 0.3× 56 3.5k
Gustavo E. Ayala United States 32 1.8k 1.2× 1.8k 1.6× 1.3k 1.5× 820 1.4× 627 1.9× 57 4.7k
Manabu Futamura Japan 28 1.4k 0.9× 372 0.3× 1.1k 1.2× 729 1.3× 119 0.4× 126 2.7k
Fengju Chen United States 26 1.6k 1.1× 553 0.5× 680 0.8× 703 1.2× 91 0.3× 62 3.1k
Helmut Bonkhoff Germany 35 1.6k 1.1× 2.5k 2.2× 768 0.9× 618 1.1× 130 0.4× 79 4.4k
Patrick N. Harter Germany 38 1.9k 1.2× 655 0.6× 1.2k 1.4× 971 1.7× 95 0.3× 181 4.8k
M. Kelly Nicholas United States 26 1.6k 1.0× 1.2k 1.1× 863 1.0× 1.1k 1.9× 64 0.2× 64 4.5k

Countries citing papers authored by Rile Li

Since Specialization
Citations

This map shows the geographic impact of Rile Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rile Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rile Li more than expected).

Fields of papers citing papers by Rile Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rile Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rile Li. The network helps show where Rile Li may publish in the future.

Co-authorship network of co-authors of Rile Li

This figure shows the co-authorship network connecting the top 25 collaborators of Rile Li. A scholar is included among the top collaborators of Rile Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rile Li. Rile Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Frolov, Anna, et al.. (2017). Cellular interactions of the phosphorylated form of AKT in prostate cancer. Human Pathology. 63. 98–109. 4 indexed citations
2.
Agoulnik, Alexander I., Manqi Zhang, L. E. Peterson, et al.. (2016). Nuclear Receptor Corepressor 1 Expression and Output Declines with Prostate Cancer Progression. Clinical Cancer Research. 22(15). 3937–3949. 21 indexed citations
3.
Ayala, Gustavo E., Bahar Müezzínoğlu, Anna Frolov, et al.. (2011). Determining Prostate Cancer-Specific Death through Quantification of Stromogenic Carcinoma Area in Prostatectomy Specimens. American Journal Of Pathology. 178(1). 79–87. 48 indexed citations
4.
Wang, Jianghua, Yi Cai, Longjiang Shao, et al.. (2010). Activation of NF-κB by TMPRSS2/ERG Fusion Isoforms through Toll-Like Receptor-4. Cancer Research. 71(4). 1325–1333. 66 indexed citations
5.
Cai, Yi, Jianghua Wang, Rile Li, et al.. (2009). GGAP2/PIKE-A Directly Activates Both the Akt and Nuclear Factor-κB Pathways and Promotes Prostate Cancer Progression. Cancer Research. 69(3). 819–827. 34 indexed citations
6.
Dakhova, Olga, Mustafa Özen, Chad J. Creighton, et al.. (2009). Global Gene Expression Analysis of Reactive Stroma in Prostate Cancer. Clinical Cancer Research. 15(12). 3979–3989. 125 indexed citations
7.
Yan, Jun, Halime Erdem, Rile Li, et al.. (2008). Steroid Receptor Coactivator-3/AIB1 Promotes Cell Migration and Invasiveness through Focal Adhesion Turnover and Matrix Metalloproteinase Expression. Cancer Research. 68(13). 5460–5468. 90 indexed citations
8.
Ayala, Gustavo, Jun Yan, Rile Li, et al.. (2008). Bortezomib-Mediated Inhibition of Steroid Receptor Coactivator-3 Degradation Leads to Activated Akt. Clinical Cancer Research. 14(22). 7511–7518. 24 indexed citations
9.
10.
Li, Rile, Sibel Erdamar, Hong Dai, et al.. (2007). Forkhead protein FKHR and its phosphorylated form p-FKHR in human prostate cancer. Human Pathology. 38(10). 1501–1507. 25 indexed citations
11.
Gangula, Rama, Kevin W. Freeman, Rile Li, et al.. (2007). Inducible FGFR-1 Activation Leads to Irreversible Prostate Adenocarcinoma and an Epithelial-to-Mesenchymal Transition. Cancer Cell. 12(6). 559–571. 231 indexed citations
12.
Dai, Hong, Rile Li, Thomas M. Wheeler, et al.. (2006). Enhanced survival in perineural invasion of pancreatic cancer: an in vitro approach. Human Pathology. 38(2). 299–307. 87 indexed citations
13.
Ayala, Gustavo, Takefumi Satoh, Rile Li, et al.. (2006). Biological Response Determinants in HSV-tk + Ganciclovir Gene Therapy for Prostate Cancer. Molecular Therapy. 13(4). 716–728. 45 indexed citations
14.
Khor, Li‐Yan, Michelle DeSilvio, Rile Li, et al.. (2006). Bcl-2 and bax expression and prostate cancer outcome in men treated with radiotherapy in Radiation Therapy Oncology Group protocol 86-10. International Journal of Radiation Oncology*Biology*Physics. 66(1). 25–30. 30 indexed citations
15.
Ayala, Gustavo E., Hong Dai, Salahaldin A. Tahir, et al.. (2006). Stromal Antiapoptotic Paracrine Loop in Perineural Invasion of Prostatic Carcinoma. Cancer Research. 66(10). 5159–5164. 81 indexed citations
16.
Dai, Hong, Rile Li, Thomas M. Wheeler, et al.. (2005). Pim‐2 upregulation: Biological implications associated with disease progression and perinueral invasion in prostate cancer. The Prostate. 65(3). 276–286. 63 indexed citations
17.
Ayala, Gustavo E., Hong Dai, Rile Li, et al.. (2005). Bystin in perineural invasion of prostate cancer. The Prostate. 66(3). 266–272. 34 indexed citations
18.
Li, Rile, Thomas M. Wheeler, Hong Dai, et al.. (2004). High Level of Androgen Receptor Is Associated With Aggressive Clinicopathologic Features and Decreased Biochemical Recurrence-free Survival in Prostate. The American Journal of Surgical Pathology. 28(7). 928–934. 147 indexed citations
19.
Ayala, Gustavo E., Hong Dai, Michael Ittmann, et al.. (2004). Growth and Survival Mechanisms Associated with Perineural Invasion in Prostate Cancer. Cancer Research. 64(17). 6082–6090. 190 indexed citations
20.
Li, Rile, Mamoun Younes, Thomas M. Wheeler, et al.. (2003). Expression of vascular endothelial growth factor receptor‐3 (VEGFR‐3) in human prostate. The Prostate. 58(2). 193–199. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Frolov Breakdown of academic impact, for papers by Laura Rosanò Breakdown of academic impact, for papers by Erik J. Uhlmann Breakdown of academic impact, for papers by Valeriana Di Castro Breakdown of academic impact, for papers by Gustavo E. Ayala Breakdown of academic impact, for papers by Manabu Futamura Breakdown of academic impact, for papers by Fengju Chen Breakdown of academic impact, for papers by Helmut Bonkhoff Breakdown of academic impact, for papers by Patrick N. Harter Breakdown of academic impact, for papers by M. Kelly Nicholas
Rankless by CCL
2026